2 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Glofitamab in Real Lifelarge B-cell lymphomaRecruitingNot stated2026-06-03NCT06994169
Axi-Cel as a 2nd Line Therapy in Patients With Relapsed/Refractory Aggressive B Lymphoma Ineligible to Autologous Stem Cell TransplantationB-Cell Lymphoma Refractory; B-cell Lymphoma RecurrentActive, not recruitingPhase 22026-03-27NCT04531046